Department of Pharmacy Practice, Faculty of Pharmacy, International Islamic University Malaysia, Kuantan, Pahang, Malaysia; Quality Use of Medicines Research Group, Faculty of Pharmacy, International Islamic University Malaysia, Kuantan, Pahang, Malaysia.
School of Pharmacy, University of Birmingham, Edgbaston, Birmingham, UK.
Res Social Adm Pharm. 2021 Jan;17(1):1938-1941. doi: 10.1016/j.sapharm.2020.05.030. Epub 2020 May 31.
The current pandemic of the COVID-19 infection, coupled with the increased global burden of diabetes, has imposed significant challenges to the healthcare providers in providing effective and sustained care to patients with diabetes during the ongoing pandemic. It is, therefore, important for healthcare providers to understand and follow the recommended changes in the delivery of care, lifestyle modifications, and pharmacotherapy to ensure optimal care to the patients during and post-pandemic era. This commentary aims to discuss the impact of COVID-19 on diabetes care and the important considerations for pharmacists during this pandemic.
当前 COVID-19 感染的大流行，加上糖尿病全球负担的增加，给医疗保健提供者在大流行期间为糖尿病患者提供有效和持续的护理带来了重大挑战。因此，医疗保健提供者了解并遵循护理、生活方式改变和药物治疗方面的推荐变化非常重要，以确保在大流行期间和之后为患者提供最佳护理。本评论旨在讨论 COVID-19 对糖尿病护理的影响，以及在这场大流行期间药师的重要考虑因素。
